Female vaginal contraceptives are associated with increased susceptibility to infections. The prevalence of female reproductive tract infections (RTI) among contraceptive users was determined. A total of 187 female participants including 156 contraceptive users and 31 age-matched noncontraceptive users with signs and symptoms of RTIs were recruited for this study. A questionnaire was used to collect demographic information. High vaginal swabs were collected from each participant and processed using standard technique. Female contraceptive users (40.4%) had an increased risk for developing RTIs compared to noncontraceptive users (19.35%) (OR = 2.833, 95 CI = 1.095, 7.276; p = 0.044). Intrauterine device (IUD) users (53.07%; p = 0.032), users of contraceptives for less than 1 year (60.00%; p = 0.003) and age group of 26−30 years (68.18%; p = 0.0001) had significantly higher prevalence of RTIs among contraceptive users. Candida albicans was the most prevalent etiologic agent of RTIs among contraceptive users irrespective of types of contraceptives, bacteria vaginosis caused by other bacterial isolates was the most common RTIs among noncontraceptive users. In this situation, Klebsiella species was found only among IUD users. The study reveals an overall prevalence of 36.90% of female RTIs. Contraceptive users had 1−7 fold increase in developing RTIs. Vaginal candidiasis and bacterial vaginosis were the most common female RTIs observed among contraceptives and noncontraceptive users. Some valuable measures to reduce infections associated with contraceptive use are advocated.
Introduction
It is estimated that 340 millions of new cases of curable sexually transmitted infections occur each year in women and men suffering from reproductive tract infections (RTIs). 1 RTIs are the top five infectious disease in adults seeking health care, and about one third of RTIs occur globally among people younger than 25 years of age.
to prevent sexually transmitted infections and unwanted pregnancies.
Sexually transmitted disease and pelvic inflammatory disease (PID) resulting from inappropriate contraceptive method may cause infertility. 4 Certain contraceptives methods have been reported to increase host susceptibility to infections. 5 The complications of RTIs arising from the use of contraceptive methods indicate the urgent need for safe and effective tools of contraceptives. The control of RTIs, especially sexually transmitted infections, is an urgent health priority in many countries. 6 This study aims to determine the prevalence of RTIs among females using various contraceptive methods as well as their etiologic agents in Benin City, Nigeria.
Materials and Methods

Study population
A total of 187 female participants consisting of 156 contraceptive users and 31 age-matched noncontraceptive users control groups were recruited for this study. All participants had signs and symptoms of reproductive tract infections (RTIs).
Demographics, types of contraceptives and duration of contraceptive use were obtained with the aid of questionnaire. The contraceptive users were attending family planning clinic while controls were attending the Gynaecology Clinic, both in the University of Benin Teaching Hospital, Benin City, Nigeria from August 2006 to August 2008. Verbal informed consent was obtained from each patient prior to specimen collection. The study was approved by the Ethical Committee of the University of Benin Teaching Hospital.
Collection and processing of sample
A pair of high vaginal swab were collected from each patient and transported to the laboratory for analysis within 1 hour. One swab was used to make film for Gram staining. The other swab was inoculated onto chocolate agar, Blood agar, MacConkey agar and Sabourand agar for 24−48 hours. Bacterial vaginosis caused by other bacterial isolates was diagnosed using Nugent's Gram stain scoring system. Trichomonas vaginalis was identified by its typical morphology and motility on wet mount of high vaginal swab. Candidiasis was diagnosed by the presence of yeast-like cell in wet mount as well as fungal culture. Gonorrhoea was diagnosed by the presence of intracellular Gram negative diplococci and/or identification of bacterial culture. Bacterial isolates were identified using standard laboratory techniques. 7 
Statistical analysis
The data obtained were analyzed using the χ 2 test and odds ratio (OR) by using the statistical software InStat (GraphPad Software, Inc., La Jolla, CA, USA).
Results
The effect of demographics on the prevalence of female RTIs among users of contraceptives is shown in Table 1 . A total of 69 (36.90%) of the 187 patients had RTIs. Females that used contraceptives (40.38%) were at an increase risk of acquiring RTIs (OR = 2.833, 95% CI = 1.095, 7.276, p = 0.044). Female patients using IUD had significantly (p = 0.032) higher prevalence of RTIs compared with those that used other methods. The longer the use of contraceptives, the lower the prevalence of RTIs as the prevalence fell from 60% for the less-than-1-year users to 10% for the 11−15-year users. This was statistically significant (p = 0.003). The prevalence of RTIs among female contraceptive users was significantly (p < 0.0001) higher in the age group of 26−30 years (68.18%).
In RTIs, Candida albicans was the most prevalent agents among different methods of contraceptive users. It was also the only isolate among spermicidal condom user. Klebsiella species and Staphylococcus aureus were only recovered from IUD and injectable users respectively ( Table 2) .
Discussion
Genital and urinary tract diseases due to contraceptive methods contributed to the sequelae of infertility, ectopic pregnancy, PID and its higher mortality and morbidity rates among neonates and their mothers. 8 This study focused on determining the prevalence of RTIs among women using various contraceptive methods as well as nonusers. The effect of demographics on prevalence and etiologic agents were also determined.
A total of 69 (36.90%) of the 187 participants had RTIs. This was lower than that of data previously reported. 9 The difference could be because of the source of patients used in this study; we included only out-patients attending the Obstetrics and Gynaecology, and Antenatal Clinics. However, the participants in data of Omoregie et al 9 report included both in and out-patients.
Females using various contraceptive methods had approximately 1−7 fold increase in risk of acquiring RTIs compared to noncontraceptive users. This agrees with other previous reports. 8, 10 Procedures for manipulations of contraceptive methods in female genital tract is well known to increase the risk for female genital tract infections. 10 The prevalence of RTIs is higher in IUD users than that of other contraceptive methods. This agrees with other previous reports. 6 The procedure of insertion of IUD is not an aseptic method which may push vaginal and cervical bacteria into the uterus from the tail of the device. 5 The results in this study indicate that the longer the uses of contraceptive methods, the lower the prevalence of RTIs. This result was significant (p = 0.003). There is an increased chance of infections among contraceptive users, particularly IUD users, within the first few weeks of use. 5, 11 Contraceptive methods with the use of hormone have been reported to lower immunity. 12 It is possible to reduce immunity and give rise to RTIs during the early weeks of contraceptive usage. As the duration of contraceptive usage increases, the body may be developing the immunity needed to increase the ability against invading microorganisms and reducing the prevalence of female RTIs. This condition may explain the findings obtained in this study.
The highest prevalence of female RTIs among contraceptive users was significantly (p < 0.0001) affected by age in the group of 26−30-year-olds. The reason behind this requires further studies. The level of education of female contraceptive users did not significantly affect the prevalence of RTIs among contraceptive users, although the prevalence increases The high prevalence of C. albicans among oral contraceptive users had previously been noted. 8 The increased rate of infection with C. albicans among female oral contraceptive users is believed to be due to the effect of female hormones on glycogen availability and adherence of C. albicans to epithelial cells with yeast virulence. 8 Other predisposing factors of vaginal candidiasis include tight nylon underwear, poor ventilation and temperature increase and moisture of the perineum. 13 Bacteria vaginosis is reported to be more highly prevalent among women using IUD. 8 This is not in agreement with findings in this study. Oral contraceptives are also reported to be associated with Gardenella vaginalis. 14 No finding of Trichomonas vaginalis in RTIs among condom users has previously been noted. 15 Condoms are effective barriers in preventing sexually transmitted disease caused by various pathogenic microorganisms. 8 Finding of Klebsiella species in users with IUD method of contraception was in agreement with other pervious reports. 8 Among controls group of noncontraceptive users, bacterial vaginosis and vaginal candidiasis were the only RTIs observed (data not shown) with higher prevalence of bacteria vaginosis (12.90%) compared with (6.50%) of vaginal candidiasis. The prevalence of bacteria vaginosis and vaginal candidiasis were higher among female contraceptive users compared with noncontraceptive users indicating that contraceptives increase risk in acquiring bacterial vaginosis and vaginal candidiasis.
In conclusion, an overall prevalence of 36.90% of female RTIs was observed in this study. Contraceptive users have a 1−7-fold increased risk of acquiring female RTIs and users of IUD have higher prevalence of RTIs. Prevalence of RTIs decreased with increase duration of contraceptive use. C. albicans was the most prevalent agent causing RTIs among contraceptive users. However, bacterial vaginosis was the most prevalent case in RTIs among noncontraceptive users. Some valuable measures to reduce infections associated with contraceptive use are advocated.
